Kick-Off Meeting - April 24th 2018

Kick-Off Meeting

April 24th 2018

Annual Meeting 2019 - April 4th-5th 2019

Annual Meeting 2019

April 4th-5th 2019

Sommer School 2019 - September 25th-27th 2019

Sommer School 2019

September 25th-27th 2019

Annual Meeting 2020 - January 15th-16th 2020

Annual Meeting 2020

January 15th-16th 2020

AMPro in brief

All centers of the Helmholtz Health Research Section are working together with the aim of exploring innovative prevention and treatment approaches to age-related diseases. More...

News & Events

Concluding Meeting 2021

March 2021
Further information will be provided in time.


Get to know the AMPro Scientists!

Each week, we present you one AMPro scientist in more detail.

This week: Natalia Rodriguez-Muela

The latest AMPro publications

Ihab Ansari et al.
The microbiota programs DNA methylation to control intestinal homeostasis and inflammation.
Nature Microbiology. February 2020.

Ilaria Bellantuino et al.
A toolbox for the longitudinal assessment of healthspan in aging mice.
Nature protocols. January 2020.

Fangfang Chen et al.
Crystal structure of cis-aconitate decarboxylase reveals the impact of naturally occurring human mutations on itaconitate synthesis.
Proceedings of the National Academy of Sciences. September 2019.

Kühn Tilman et al.
Pre-diagnostic plasma bile acid levels and colon cancer risk: A prospective study.
Journal of the National Cancer Institute. August 2019



Contact - Project Management

Dr. Claudia Prothmann

Institute for Diabetes and Cancer IDC
Helmholtz Center Munich (HMGU)
Ingolstädter Landstraße 1
85764 Neuherberg
Phone: +49 89 3187-49394


Dr. Sabine Rehberger-Schneider

Division of Signal Transduction in Cancer and Metabolism
German Cancer Research Center (DKFZ) - B140
Im Neuenheimer Feld 580
69120 Heidelberg
Phone: +49 6221 42-1628

AMPro - Aging and Metabolic Programming

Most chronic diseases such as diabetes, cancer, cardiovascular, respiratory and neurodegenerative diseases as well as chronic infections increase in incidence with age. This indicates common age-related mechanisms acting jointly. Due to increasing life expectancy throughout the world, those age-related diseases are emerging as a growing challenge for patients, doctors, the healthcare system and society as a whole.


Among other things, the AMPro consortium is seeking out new preventive and therapeutic approaches that have a positive effect on metabolic processes. This should enable the innovative and consistent treatment of age-related diseases. The following key aspects of metabolic processes associated with aging will be investigated.


Metabolic pre- and reprogramming 
Prenatal and postnatal mechanisms of metabolic programming at the genetic and epigenetic levels

Inter-organ signaling
Mechanisms of organ and tissue communication

Stem cell function and tissue maintenance 
Tissue and cellular repair mechanisms


The long-term goal is to improve health in an aging society. AMPro creates ideal conditions for successfully tackling one of the most pressing issues in today's society and meeting the challenges of age-related diseases.